Research workspace · registry aware

Cancer Research Platform

A pipeline-guided workspace for molecular characterization, evidence exchange, and reproducible research reporting.

Explore the pipeline

Cancer Discovery Pipeline

Seven-stage research framework
  1. Data
  2. Molecular state
  3. Biomarkers
  4. Vulnerabilities
  5. Pharmacology
  6. Validation
  7. Report

Documentation

Contracts, registries, and extension guidance.

Documentation distinguishes the public research journey from the independently versioned project manifests that implement its modules.

Platform references

Core documentation

Start with the architecture contract before adding data, schemas, or project modules.

Module references

Registered manifest documentation

Links are resolved from each web-enabled project manifest.

  • P001 · v0.3.0

    Molecular State Explorer

    Research-only molecular-state modeling project with independently versioned task contracts. T001 includes metadata and read-only compatibility validation for the completed legacy TCGA-BRCA TP53 candidate. The current platform specification remains unapproved and cannot pass G0 or produce a release.

    Open declaration
  • P002 · v0.1.0

    Cancer Vulnerability Explorer

    Contract scaffold for integrating molecular-state evidence with functional, pharmacological, and proteomic evidence to evaluate candidate vulnerabilities. No vulnerability analysis or validation is implemented.

    Open declaration

Interpretation guardrails

Research workspace boundaries

  • Project registration does not establish analytical completion or scientific validity.
  • Planned dataset entries do not imply data access, download, harmonization, or approval.
  • Artifact schemas define exchange contracts; only artifact records represent published outputs.
  • The platform is not for diagnosis, medical advice, patient-level inference, or clinical decisions.